"... this award justifies our belief in the exceptional quality of our team,” said Mark Lacy, founder and CEO of Benchmark Research.
Austin, TX (PRWEB) April 09, 2014
Benchmark Research’s New Orleans location has won the “Best Clinical Trial Site & Trial Network” category for the 2014 Vaccine Industry Excellence (ViE) Awards. Winners were presented at the 14th Annual World Vaccine Congress held in Washington, D.C. on March 25, 2014. The only awards ceremony dedicated to the vaccine industry, the ViE Awards honor individuals, organizations and initiatives, which have made significant contributions to the industry over the past 12 months.
Benchmark Research is a network of therapeutically diverse centers that specialize in vaccine research; Benchmark sets the standard in this competition, having been recognized consecutively within the Best Clinical Site and/or Trial Network category since the inception. “Scott and I could not be more proud of our entire Benchmark family, the dedication and commitment that everyone works toward is shown in the results of the vaccine studies we oversee; and to be recognized and honored once again with this award justifies our belief in the exceptional quality of our team,” said Mark Lacy, founder and CEO of Benchmark Research.
Started early 1997 in Texas, Benchmark Research has grown to include six premier clinical sites in Louisiana and California and continues to expand and innovate to maintain their standing as the Site Network Industry Leader of Vaccine Studies.